BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7919341)

  • 1. Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells.
    Kovach NL; Lindgren CG; Fefer A; Thompson JA; Yednock T; Harlan JM
    Blood; 1994 Oct; 84(7):2234-42. PubMed ID: 7919341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
    Jain M; Ratheesh A; Gude RP
    Chemotherapy; 2010; 56(1):82-8. PubMed ID: 20299795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components.
    Kovach NL; Carlos TM; Yee E; Harlan JM
    J Cell Biol; 1992 Jan; 116(2):499-509. PubMed ID: 1370496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
    Roussel E; Gerrard JM; Greenberg AH
    Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothymosin alpha1 effects on IL-2-induced expression of LFA-1 on lymphocytes and their adhesion to human umbilical vein endothelial cells.
    Grünberg E; Eckert K; Maurer HR; Immenschuh P; Kreuser ED
    J Interferon Cytokine Res; 1997 Mar; 17(3):159-65. PubMed ID: 9085941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components.
    Ratheesh A; Ingle A; Gude RP
    Cancer Biol Ther; 2007 Nov; 6(11):1743-52. PubMed ID: 17986856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.
    Hoskin DW; Phu T; Makrigiannis AP
    Int J Immunopharmacol; 1996 Nov; 18(11):623-31. PubMed ID: 9089006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved.
    Jääskeläinen J; Mäenpää A; Patarroyo M; Gahmberg CG; Somersalo K; Tarkkanen J; Kallio M; Timonen T
    J Immunol; 1992 Jul; 149(1):260-8. PubMed ID: 1351501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
    Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A
    Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity.
    Thompson JA; Lindgren CG; Benyunes MC; Bianco JA; Shields AF; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Feb; 13(2):84-90. PubMed ID: 8318500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.
    Carlos TM; Schwartz BR; Kovach NL; Yee E; Rosa M; Osborn L; Chi-Rosso G; Newman B; Lobb R
    Blood; 1990 Sep; 76(5):965-70. PubMed ID: 1697486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity.
    Spagnoli GC; Juretic A; Schultz-Thater E; Dellabona P; Filgueira L; Hörig H; Zuber M; Garotta G; Heberer M
    Cell Immunol; 1993 Feb; 146(2):391-405. PubMed ID: 8174177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis.
    Alexander CL; Edward M; MacKie RM
    Melanoma Res; 1999 Feb; 9(1):31-9. PubMed ID: 10338332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion.
    Jewett A; Bonavida B
    J Clin Immunol; 1994 Jan; 14(1):31-8. PubMed ID: 8132735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells.
    Piali L; Albelda SM; Baldwin HS; Hammel P; Gisler RH; Imhof BA
    Eur J Immunol; 1993 Oct; 23(10):2464-71. PubMed ID: 8405046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B; Rees RC
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
    Rabinowich H; Sedlmayr P; Herberman RB; Whiteside TL
    J Immunol; 1993 Jun; 150(11):4844-55. PubMed ID: 8496590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion characteristics of human interleukin 2-activated natural killer cells.
    Melder RJ; Walker E; Herberman RB; Whiteside TL
    Cell Immunol; 1991 Jan; 132(1):177-92. PubMed ID: 1905985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentative effects of phytohemagglutinin-P on proliferation and cytotoxicity of interleukin-2-activated canine peripheral blood lymphocytes.
    Mizuno S; Fujinaga T; Kurosawa T
    Zentralbl Veterinarmed A; 1996 Jul; 43(5):289-96. PubMed ID: 8779803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.